197
Participants
Start Date
January 17, 2018
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2031
Nasofibroscopy
every 1-3 months first year post-treatment, every 2-4 months second year, every 4-6 months third year (mean of around 13 visits) and every 6 months thereafter
Low Dose Chest CTscan
every year in patients with tobacco consumption history of \> 20 pack-year
injected CT-scan
the first performed 12 months after inclusion
whole body PET-CT
annual whole body PET-CT (the first at 6 months after inclusion)
Lugol upper gastrointestinal endoscopy
the first performed 12 months after inclusion
Biopsy
In both arm, patient will have a confirmation biopsy in case of suspicion of relapse or second primary.
Gustave Roussy, Villejuif
National Cancer Institute, France
OTHER_GOV
Gustave Roussy, Cancer Campus, Grand Paris
OTHER